This company has been marked as potentially delisted and may not be actively trading. Elicio Therapeutics (ELTX) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Elicio Therapeutics (NASDAQ:ELTX)CurrentInstitutional OwnershipPercentage35.03%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$1.13MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$50K Get ELTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Elicio Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ELTX Institutional Buying and Selling by Quarter Elicio Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/4/2025Mayflower Financial Advisors LLC10,000$77K0.0%N/A0.063% 5/19/2025Jane Street Group LLC14,993$92K0.0%N/A0.139% 5/15/2025Royal Bank of Canada36,537$225K0.0%N/A0.339% 5/9/2025CM Management LLC55,000$339K0.3%+37.5%0.510% 4/28/2025 Moody Lynn & Lieberson LLC10,000$62K0.0%N/A0.093% 2/7/2025CM Management LLC40,000$204K0.2%-20.0%0.371% 8/15/2024Armistice Capital LLC100,000$411K0.0%N/A0.978% 8/9/2024Warberg Asset Management LLC11,801$49K0.0%N/A0.115% 8/2/2024CM Management LLC50,000$206K0.2%-33.3%0.489% 5/14/2024CM Management LLC75,000$570K0.5%+50.0%0.733% 8/4/2023CM Management LLC65,000$618K0.6%N/A2.159% (Data available from 1/1/2016 forward) ELTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ELTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Elicio Therapeutics shares: Armistice Capital LLC ($411K), CM Management LLC ($339K), Royal Bank of Canada ($225K), Jane Street Group LLC ($92K), Mayflower Financial Advisors LLC ($77K), and Moody Lynn & Lieberson LLC ($62K), and Warberg Asset Management LLC ($49K).Learn more on Elicio Therapeutics' institutional investors. What percentage of Elicio Therapeutics' stock is owned by institutional investors? 35.03% of Elicio Therapeutics' stock is owned by institutional investors. Learn more on ELTX's institutional investor holdings. Which institutional investors have been buying Elicio Therapeutics' stock? The following institutional investors have purchased Elicio Therapeutics' stock in the last 24 months: CM Management LLC ($105K), Armistice Capital LLC ($100K), Royal Bank of Canada ($36.54K), Jane Street Group LLC ($14.99K), Warberg Asset Management LLC ($11.80K), Mayflower Financial Advisors LLC ($10K), and Moody Lynn & Lieberson LLC ($10K). How much institutional buying is happening at Elicio Therapeutics? Institutional investors have bought a total of 198,331 shares in the last 24 months. This purchase volume represents approximately $1.13M in transactions. Which of Elicio Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Elicio Therapeutics stock in the last 24 months: CM Management LLC ($10K). How much institutional selling is happening at Elicio Therapeutics? Institutional investors have sold a total of 10,000 shares in the last 24 months. This volume of shares sold represents approximately $50K in transactions. Related Companies ABUS Institutional Ownership PHAT Institutional Ownership TYRA Institutional Ownership BCYC Institutional Ownership KROS Institutional Ownership ARVN Institutional Ownership FTRE Institutional Ownership SEPN Institutional Ownership SLDB Institutional Ownership REPL Institutional Ownership This page (NASDAQ:ELTX) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elicio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elicio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELTX Stock Alerts